Bioinspired therapeutic platform based on extracellular vesicles for prevention of arterial wall remodeling in hypertension

Chen Wang,Changyang Xing,Zhelong Li,Yunnan Liu,Qiaoying Li,Yixiao Wang,Jiao Hu,Lijun Yuan,Guodong Yang
DOI: https://doi.org/10.1016/j.bioactmat.2021.06.005
IF: 18.9
2022-02-01
Bioactive Materials
Abstract:EVs derived from arterial endothelium alter significantly under hypertension.EV-mediated transfer of miR-423/320 induces VSMC synthetic phenotype switch.EVs from the injured endothelium promote arterial remodeling.Therapeutic delivery of miR-423/320 inhibitors <em>via</em> EVs alleviates arterial stiffening.Arterial stiffness due to the vessel remodeling is closely linked to raised blood pressure, and its physiopathologic mechanism is still not fully understood. We here aimed to explore whether extracellular vesicle (EV) mediated intercellular communication between endothelium and smooth muscle cell contribute to the blood vessel remodeling under hypertension. We here revealed that the arterial endothelial cells robustly secreted EV, which in turn could be circulated and/or directly taken up by the subendothelial smooth muscle cells (SMC). Under hypertension, the EV secretion increased and the miRNA profile changed significantly mainly due to the raised mechanical force and subsequent enhanced reactive oxygen species generation. Among the miRNA cargos in the EV, miR-320d/423-5p were found increased most significantly. <em>In vivo</em> delivery of miR-320d/423-5p mimics <em>via</em> engineered EV increased their expression in arterial vessels, recapitulating the phenotype in hypertension. In contrast, therapeutic delivery of miR-320d/423-5p inhibitors <em>via</em> engineered EV alleviated the phenotype in spontaneous hypertension rat model. Together, we have found that the injured endothelium due to the raised mechanical force in hypertension contributes to the arterial wall remodeling <em>via</em> the secreted EV. Our study has not only provided novel insights on the mechanism of hypertension associated blood vessel wall remodeling, but also shed light on therapeutic intervention of hypertension associated vascular diseases.High blood pressure alters the EV secretion and the component profile. In turn, the altered EVs are taken up by the subendothelial smooth muscle cells and deliver the encapsulated cargos, such as miR-423 into the recipient cells, resulting in the phenotype switch and blood vessel wall structure remodeling. The remodeled blood vessel structure further increases the blood pressure, forming a vicious cycle. <em>In vivo</em> delivery of therapeutic EVs antagonizing miR-320/423 function in hypertension rat model partially reverses the disease phenotype.<span class="display"><span><ol class="links-for-figure"><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S2452199X21002887-ga1_lrg.jpg"><span class="anchor-text">Download : <span class="download-link-title">Download high-res image (407KB)</span></span></a></li><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S2452199X21002887-ga1.jpg"><span class="anchor-text">Download : <span class="download-link-title">Download full-size image</span></span></a></li></ol></span></span>
engineering, biomedical,materials science, biomaterials
What problem does this paper attempt to address?